PatentVerwendung von amphiphilen Nucleosid-Phosphonoameisensäure-Derivaten zur Behandlung von viralen…
Basic data
Title:
Verwendung von amphiphilen Nucleosid-Phosphonoameisensäure-Derivaten zur Behandlung von viralen Infektionskrankheiten
Reference number (DPMA):
102 28 059.2
Primary registration:
19/06/2002
Approval:
27/07/2005
Abandoment:
01/01/2010 (expired)
Inventors
Hamprecht, Klaus
Institute of Medical Virology and Epidemiology of Viral Diseases
Department of Diagnostic Laboratory Medicine, Hospitals and clinical institutes, Faculty of Medicine
Department of Diagnostic Laboratory Medicine, Hospitals and clinical institutes, Faculty of Medicine
Faculty of Medicine
University of Tübingen
University of Tübingen
Institute of Organic Chemistry
Department of Chemistry, Faculty of Science
Department of Chemistry, Faculty of Science
Local organizational units
Institute of Medical Virology and Epidemiology of Viral Diseases
Department of Diagnostic Laboratory Medicine
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
National patents
PCT Registration
Registration date:
07/06/2003
Registration number:
PCT/EP2003/006012
Nationalizations
Patent familiy:
102 28 059.2, 03760597, US11/015,209, AU2003242652
03760597
European Patent Office
07/06/2003
13/02/2008
US11/015,209
USA: United States Patent and Trademark Office
16/12/2004
09/10/2007
09/11/2015 (expired)
AU2003242652
Australien: IP Australia
07/06/2003
25/02/2005 (expired)